NEW YORK, NY / ACCESSWIRE / September 22, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI)'s sale to Alcon for $15.25 per share. If you are an Aerie shareholder, click here to learn more about your rights and options.
CyberOptics Corporation (NASDAQ:CYBE)'s sale to Nordson Corporation for $54.00 per share. If you are a CyberOptics shareholder, click here to learn more about your rights and options.
Gemini Therapeutics, Inc. (NASDAQ:GMTX)'s merger with Disc Medicine, Inc. Pre-merger Gemini shareholders are expected to own approximately 28% of the combined company. If you are a Gemini shareholder, click here to learn more about your rights and options.
Meridian Bioscience, Inc. (NASDAQ:VIVO)'s sale to SD Biosensor, Inc. and SJL Partners LLC for $34.00 per share in cash. If you are a Meridian shareholder, click here to learn more about your rights and options.
Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
SOURCE: Halper Sadeh LLC